Unicycive Therapeutics Files Annual Report
Ticker: UNCY · Form: ARS · Filed: Apr 30, 2026 · CIK: 0001766140
| Field | Detail |
|---|---|
| Company | Unicycive Therapeutics, Inc. (UNCY) |
| Form Type | ARS |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Unicycive filed its 2025 ARS. Check it for performance updates.
AI Summary
Unicycive Therapeutics, Inc. filed its Annual Report to Security Holders (ARS) on April 30, 2026, for the period ending December 31, 2025. The company is based in Mountain View, California, and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides shareholders with an overview of the company's performance and financial standing for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material information that would immediately impact risk.
Key Numbers
- 2025-12-31 — Period of Report (Indicates the end date for the financial reporting period.)
- 2026-04-30 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- Unicycive Therapeutics, Inc. (company) — Filer
- 0001766140 (company) — CIK
- 1975 W. EL CAMINO REAL, SUITE 204 MOUNTAIN VIEW CA 94040 (address) — Mailing and Business Address
FAQ
What is the primary purpose of the ARS filing?
The ARS (Annual Report to Security Holders) provides shareholders with a comprehensive overview of the company's activities and financial performance for the past fiscal year.
When was the period of report for this filing?
The period of report for this filing was December 31, 2025.
What is Unicycive Therapeutics, Inc.'s CIK number?
Unicycive Therapeutics, Inc.'s CIK number is 0001766140.
Where is Unicycive Therapeutics, Inc. located?
Unicycive Therapeutics, Inc. has its mailing and business address at 1975 W. EL CAMINO REAL, SUITE 204 MOUNTAIN VIEW CA 94040.
What industry does Unicycive Therapeutics, Inc. operate in?
Unicycive Therapeutics, Inc. operates in the Pharmaceutical Preparations sector (SIC code 2834).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 30, 2026 regarding Unicycive Therapeutics, Inc. (UNCY).